adenine and cudc-907

adenine has been researched along with cudc-907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, M; Bell, T; Gong, T; Guo, H; Huang, S; Jiang, C; Li, CJ; Liu, Y; Lorence, E; Nomie, KJ; Wang, M; Yao, J; Yao, Y; Zeng, D; Zhang, H; Zhang, L; Zhou, S	1

Other Studies

1 other study(ies) available for adenine and cudc-907

Article	Year
Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma. Oncogene, 2019, Volume: 38, Issue:11 Topics: Adenine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Histones; Humans; Lymphoma, Mantle-Cell; Male; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Pyrazoles; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays	2019

Article

Year

Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.

Oncogene, 2019, Volume: 38, Issue:11

Topics: Adenine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Histones; Humans; Lymphoma, Mantle-Cell; Male; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Pyrazoles; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays

2019